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Abstract
The following case describes the presentation, diagnosis, and treatment of a 49 year-old patient with
back pain in the thoracic spine and lower extremity edema. His initial presentation, coupled with a
history of trauma, required an extensive work-up to determine the source of the back pain and
edema. The patient was determined to have two thoracic vertebral compression fractures, bilateral
lower extremity edema of unknown origin, and osteoporosis. After diagnosis, several specialists were
consulted to determine the cause of the patient’s osteoporosis. Treatment consisted of kyphoplasty,
physical therapy, and medication to prevent the progression of osteoporosis.
Introduction
Compression fractures are most commonly seen in elderly
females secondary to osteoporosis [1,2]. Due to their
increased risk of developing fractures, this patient popula-
tion is well screened for osteoporosis [2]. Unfortunately,
younger patients, especially young men, may not be
diagnosed with osteoporosis, even when they have multi-
ple risk factors for developing the disease. Currently, the
literature indicates that males between 50 and 69 years-old
should have a DEXA scan if they have multiple risk factors
for developing osteoporosis [2]. This guideline fails to
identify those individuals under age 50, at high risk of
developing osteoporosis. This case presentation describes
a male with multiple risk factors who failed to be screened
for osteoporosis.
Case presentation
A 49 year-old Caucasian male presented with progressively
worsening pain in the thoracic spine for 10 days and
painful bilateral lower extremity edema. The patient had a
history of lower thoracic and lumbar vertebral fractures,
which resulted from a traumatic fall down a flight of stairs
three months prior to this hospitalization. Those vertebral
fractures were treated with six serial kyphoplasty proce-
dures, with the final two vertebral fractures having been
treated three weeks prior to his current hospitalization.
On admission, the patient was found to have severe
persistent asthma and HIV. Psychosocial history was
positive for a twelve-year history of IV drug abuse and a
twenty-year history of alcohol dependence. He stopped
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thorough review of systems revealed increased fatigue and
weakness since his traumatic fall. He also noted that he
began developing “stretch marks” on his abdomen one
month prior to this admission. The remainder of the
review of systems was unremarkable.
Physical exam revealed an afebrile, obese male grimacing
in severe pain, with no signs of cyanosis. He was 175 cm
tall, weighed 129 kg, and had a BMI of 42.1. Vitals were as
follows: BP: 154/98; RR: 28; HR: 82; Temp: 97.7F; O2 Sat:
98% on room air. The patient was alert and oriented to
person, place, and time. Diffuse bilateral wheezes were
present on chest auscultation. Large diffuse striae covered
the entire abdomen. Bilateral 2/4 lower extremity edema
was present. Dorsalis pedis pulses were 1/4 bilaterally.
Capillary refill was within the normal range at 1.5 seconds
bilaterally. The remainder of the physical exam was
unremarkable and within normal limits.
The initial differential diagnosis was quite broad and
included the following diagnoses: lower extremity edema
of unknown origin, thoracic disk herniation, osteomyeli-
tis, vertebral compression fracture, lower extremity arterial
stenosis, and deep vein thrombosis (DVT). In order to
determine the source of his pain and edema, laboratory
and imaging studies were performed. Due to the patient’s
history of vertebral compression fractures and disk
herniation, an MRI of the thoracic spine was ordered.
The MRI revealed new compression fractures at T6 and T7,
with no changes in disk appearance from the MRI taken
three months prior. Arterial stenosis was suspected
because the patient had decreased dorsalis pedis pulses
bilaterally. A bilateral lower extremity multilevel arterial
Doppler ultrasound displayed normal triphasic wave-
forms throughout both lower extremities, and the Ankle
Brachial Index was 1.0 at the distal point in both the right
and left lower extremity. A bilateral venous Doppler was
negative for DVT. A dual energy x-ray absorptiometry
A DEXA scan was ordered to screen for osteoporosis. The
patient had a bone mineral density (BMD) of -2.8. BMD
that is 2.5 standard deviations below the mean (T-score
-2.5) is considered osteoporosis [1].
Laboratory evaluation revealed a hemoglobin of 12.5 g/dl
and a hematocrit of 37%. The white blood cell (WBC)
count was 10.2 ¥ 10
3/mm
3 and the CD4+ count was
312 cells/ml. ACTH and cortisol levels were ordered
because Cushing syndrome was suspected given the
patient’s body habitus and the presence of abdominal
striae. The ACTH level was 2.1 (normal: 9-52 pg/ml) and
the cortisol level was 3.7 µg/dl (normal: 5-24). An ACTH
stimulation test resulted in a final cortisol level of 19.1 µg/
dl, which indicated Cushing syndrome was secondary
to exogenous steroid use. Given the patient’s history of
HIV and osteoporosis, an androgen profile was also order
to determine if the patient had hypogonadism. The
following results were obtained: FSH: 6.2 IU/L (normal:
1.5-12.4 IU/L), LH: 8.9 IU/L (normal: 7.0-24.2 IU/L), total
testosterone 271 ng/ml (normal: 350-890 ng/ml) and free
testosterone: 37 pg/ml (normal: 44-244 pg/ml).
The imaging determined that the patient had vertebral
compression fractures at T6-T7 and ruled out a new
thoracic disk herniation and osteomyelitis as the source
of pain. The laboratory studies, coupled with clinical
examinations determined that that patient had steroid-
induced Cushing syndrome, hypogonadism, and osteo-
porosis. Treatment consisted of kyphoplasty of T6-T7 to
improve the vertebral defect, physical therapy to decrease
the patient’s lower extremity edema, and medication
changes to treat his hypogonadism, osteoporosis and
steroid-induced Cushing syndrome. The patient was
prescribed 10 g daily of testosterone topical (1%) to
treat the hypogonadism. Calcium 1200 mg/day, ergocal-
ciferol 50,000 units weekly, andalendronate 70 mg weekly
were used to treat the osteoporosis. The patient was
changed from fluticasone/salmeterol 500/50 one puff BID
to 100/50 one puff BID and was started on theophylline
400 mg/day. Following these treatment modalities, the
patient was able to increase his ambulation, which
resulted in decreased leg edema and pain. At the time of
discharge, the patient had minimal thoracic spine pain
and trace lower extremity edema.
Discussion
This case demonstrates how HIV, steroid-induced Cushing
syndrome, and hypogonadism can combine to cause
osteoporosis in a middle-aged male. The case also displays
how severe osteoporosis can lead to a disastrous outcome
following trauma. This discussion will address the risk
factors leading to the development of osteoporosis in our
patient, as well as the modalities used to treat the patient.
Glucocorticoids are the leading cause of medication-
induced osteoporosis [3]. Fracture risk increases within
three months of starting oral or high-dose inhaled
glucocorticoids [3]. Glucocorticoids increase bone loss
by multiple mechanisms including: inhibition of osteo-
blast function, stimulation of bone resorption, increase in
urinary calcium loss, decrease in calcium absorption, and
reduction in adrenal and testicular androgen secretion.
Bisphosphonates are the cornerstone of treatment for
steroid-induced osteoporosis [3]. Decreasing the amount
of inhaled fluticasone and adding alendronate were two
methods used to treat this patient’s osteoporosis and these
modalities are the favored modalities in the literature.
Due to the severity of the patient’s osteoporosis, 20 mcg of
teriparatide daily for six months to two years could have
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has been shown to have a greater efficacy in preventing
vertebral fractures than alendrote and other bisphospho-
nates [4]. If teriparatide was used, the bisphosphonate
should have been discontinued. The literature indicates
that there is no added benefit to taking a bisphosphonate
with teriparatide [4].
There is a controversy as to whether highly active anti-
retroviral therapy (HAART) is responsible for decreased
bone density in HIV patients or if the disease itself is a risk
factor for osteoporosis. A recent study indicates that
patients taking HAART therapy are at increased risk of
developing osteopenia and osteoporosis due to the
adverse effects protease inhibitors (PIs) have on conver-
sion of (25)-OH vitamin D to (1,25)-OH vitamin D. An in
vitro study demonstrated that ritonavir, indinavir, and
nelfinavir decreased conversion to active vitamin D by
80%, 66%, and 31%, respectively [5]. Another group
found that although HIV-positive patients tend to have
low BMD, the BMD is independent of the treatment type.
In the study, one third was treated with PIs, one third was
treated without PIs, and one third elected to have no
treatment. The study showed no significant difference
between the three groups with regards to BMD [6].
There are only a few studies that have evaluated whether
switching HAART can be beneficial. One study evaluated
18 patients who switched from a protease inhibitor-based
regimen to a non-nucleoside reverse transcriptase inhibi-
tor-based regimen. No improvements in BMD were
observed on DEXA scanning after 48 weeks of follow-up
in these patients [7]. Changing HAART is currently not
recommended because no studies have shown that
changing therapy will improve BMD [7]. As a result, our
patient was continued on his HAART regiment after he was
diagnosed with osteoporosis.
Men infected with HIV are more likely to be hypogonadal,
as judged by generally lower serum testosterone concen-
trations, than men without HIV [8]. Hypogonadism is the
best-characterized risk factor for osteoporosis in men.
Although the cause of hypogonadism in HIV-infected
males remains unclear, the presence of hypogonadism
significantly increases the risk of osteoporosis in these
patients. Providing supplemental testosterone to hypogo-
nadal patients has been shown to decrease the number of
osteoporotic fractures when used as an adjunct to bispho-
sphonates [9].
Kyphoplasty was used to repair the patient’s compression
fractures. Studies have shown that kyphoplasty is an
effective means to increase vertebral height and decrease
kyphosis following vertebral compression fractures.
Kyphoplasty was used instead of vertebroplasty because
kyphoplasty completely restores vertebral body height in a
greater percentage of patients than vertebroplasty [10].
A post-operative adverse effect of kyphoplasty and
vertebroplasty is the development of new vertebral
fractures [11,12]. Two retrospective studies found that
patients treated with vertebroplasty had an increased rate
of new vertebral fractures [11,12]. In a study with 432
patients treated with vertebroplasty, 84 patients had new
vertebral fractures occurring within four months of the
procedure [11]. In another study composed of 177
patients, 22 patients developed at least one vertebral
fracture following vertebroplasty and 67 percent of the
fractures involved adjacent vertebrae [12].
The cause of our patient’s new vertebral fractures was likely
multifactorial. Both osteoporosis and alteration of
mechanical forces on adjacent vertebrae secondary to
kyphoplasty led to the development of compression
fractures at T6 and T7. Since the patient had a history of
severe persistent asthma, it was necessary to perform
kyphoplasty in order to prevent the development of a
severe kyphosis and a subsequent restrictive lung disease.
Conclusion
This case demonstrates that gender and age cannot be the
only variables used to determine if a patient warrants
screening for osteoporosis. Our patient had not been
screened for osteoporosis in the past because he was male
and less than 50 years of age. He should have been
screened because he had multiple risk factors for devel-
oping osteoporosis. A lack of screening, coupled with his
risk factors and a traumatic fall resulted in severe vertebral
injury, which continued to plague this patient for well over
three months. Our patient illustrates the importance of
screening patients with multiple risk factors for osteo-
porosis, especially those with a history of severe persistent
asthma, HIV, and hypogonadism.
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